I found the Control No. 250480 for this trial in the ‘No Objection’ letter. Search by this Control No. on this site https://health-products.canada.ca/ctdb-bdec/search-recherche.do and you will get the information that I have copied below.
Clinical trial information
From Health Canada
New search
Medical condition:
CORONAVIRUS DISEASE (COVID-19)
Study population:
ADULT FEMALE, ADULT MALE
Drug name:
RVX000222 (APABETALONE)
Protocol title:
AN OPEN-LABEL STUDY TO ASSESS THE SAFETY AND EFFECT ON CLINICAL COURSE AND KEY BIOMARKERS OF ORAL APABETALONE IN HOSPITALIZED SUBJECTS WITH COVID-19 INFECTION IN ADDITION TO STANDARD OF CARE (SOC)
Protocol number:
RVX222-CS-023
Sponsor name:
RESVERLOGIX CORP
Date of no objection letter:
2021-04-06
Control number:
250480
Trial status:
PENDING
Date study started:
Date study completed:
